title: Rationalizing the use of NGAL in the intensive care unit.
authors: Neil J
authors: NJ
authors: Glassford
authors: Glenn M
authors: GM
authors: Eastwood
authors: Helen
authors: H
authors: Young
authors: Leah
authors: L
authors: Peck
authors: Antoine G
authors: AG
authors: Schneider
authors: Rinaldo
authors: R
authors: Bellomo
mesh_terms: D058186:Acute Kidney Injury / Q000175:diagnosis* / Q000628:therapy; D000209:Acute-Phase Proteins / Q000032:analysis*; D015415:Biomarkers / Q000032:analysis; D003404:Creatinine / Q000097:blood; D006801:Humans; D007362:Intensive Care Units; D000071068:Lipocalin-2; D054834:Lipocalins / Q000032:analysis*; D011518:Proto-Oncogene Proteins / Q000032:analysis*
chemical_list: D000209:Acute-Phase Proteins; D015415:Biomarkers; C489506:LCN2 protein, human; D000071068:Lipocalin-2; D054834:Lipocalins; D011518:Proto-Oncogene Proteins; D003404:Creatinine